Saturday 17 October 2026 Export BRTX’s income statement to Excel — free account

Biorestorative Therapies, Inc.

Biorestorative Therapies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $359,700.00, down 10.3% from fiscal 2024. In the quarter to March 2026, revenue fell 7.20%, EPS grew 81.3% and free cash flow fell 35.3%, each against the same quarter a year earlier.

1.52 0.06 +4.11%

Follow BRTX

Alert me

Market cap: $2.0M
P/E: 0.0×
Fwd P/E: −0.8×
Dividend yield: —
F-score: 4/9
Altman Z: −70.97
Beneish M: −7.56
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Mar '26	Dec '25	Sep '25	Jun '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	0.67	1.48	1.72	1.21
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(0.06)	(0.22)	(0.23)	(0.27)
P/B ratio Full definition →	0.08	1.55	0.30	0.15
Price to Tangible BV Full definition →	0.10	0.00	0.40	0.17
EV/Sales Full definition →	(8.83)	(6.20)	(9.49)	(10.67)
EV/EBITDA Full definition →	0.23	0.14	0.25	0.50
EV/Operating CF Full definition →	0.27	0.21	0.34	0.68
EV/FCF Full definition →	0.24	0.18	0.30	0.60
Quick Ratio Full definition →	2.23	0.80	1.31	2.01
Current Ratio Full definition →	2.35	0.84	1.37	2.07
Net Debt/EBITDA Full definition →	1.08	0.78	1.23	2.27
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.05	0.04	0.04	0.05
Operating CF/Net income Full definition →	1.77	0.75	0.95	1.01
Capex/Depreciation Full definition →	0.00	(1.51)	0.00	0.00
Interest Coverage Full definition →	615.58	41.72	—	44.73
Research and Development Expense of Revenue Full definition →	8,303.02%	13,403.57%	21,989.83%	733.89%
Selling, General and Administrative Expense of Revenue Full definition →	6,358.62%	6,204.59%	9,453.39%	453.02%
Intangible Assets out of Total Assets Full definition →	0.11	0.13	0.10	0.07
Share Based Compensation of Revenue Full definition →	1,250.86%	2,284.69%	3,389.83%	154.53%
Graham Net Nets Full definition →	9.13	(1.10)	1.92	5.38
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(7,925.93%)	(2,694.92%)	(2,027.59%)	(1,520.96%)
Free Cash Flow Yield Full definition →	(5,477.46%)	(2,276.49%)	(1,807.42%)	(1,480.21%)
Revenue per Share Full definition →	0.03	0.04	0.03	0.69
Operating CF per Share Full definition →	(4.30)	(5.37)	(6.36)	(6.16)
Capex per Share Full definition →	0.00	(0.18)	0.00	0.00
Free Cash Flow per Share Full definition →	(4.30)	(5.55)	(6.36)	(6.16)
Cash per Share Full definition →	4.05	6.57	9.85	16.89
Shareholders Equity per Share Full definition →	3.41	0.79	4.84	11.09
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	3.41	0.79	4.84	11.09
Free Cash Flow Full definition →	(3.81)	(2.49)	(2.90)	(2.69)
Working Capital Full definition →	2.19	(0.59)	1.27	3.93
Capital Expenditures Full definition →	—	(0.08)	0.00	0.00
Net Current Asset Value Full definition →	2.19	(0.59)	1.27	3.93
EV/EBIT Full definition →	0.22	0.14	0.25	0.49
Capex to Sales Full definition →	0.00	4.07	0.00	0.00
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	0.02	0.10	0.09	0.02
Average Payables Full definition →	0.63	0.91	0.63	0.41
Average Assets Full definition →	7.48	8.18	10.11	12.32
Average Common Equity Full definition →	4.58	4.43	6.09	7.81

Show all line items

Columns are period end dates

Stockrow Weekly